$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Tovorafenib tablets are suitable for different age groups and different patient dosage regimens and clinical guidelines.
2026-02-01 22:25:32
Check Details
Vorasidenib-VORANIGO market price and drug purchase reference instructions
2026-02-01 22:25:32
Check Details
Summary and analysis of Zongertinib clinical trial data and drug resistance
2026-02-01 22:25:32
Check Details
Vosoritide 2025 price list and market reference cost details
2026-02-01 22:25:32
Check Details
Possible adverse reactions of Pemetinib/Dabotan
2026-02-01 22:25:32
Check Details
Will tumors grow wildly after stopping the targeted drug Erdafitinib/Bocco?
2026-02-01 22:25:32
Check Details
Recommendations on the best time to take dacomitinib/dacomitinib (Dozerun) in a day
2026-02-01 22:25:32
Check Details
The mechanism of action and anti-tumor principle of brigatinib/brigatinib (Embry)
2026-02-01 22:25:32
Check Details
Where can I buy Entrectinib in the country?
2026-02-01 22:25:32
Check Details
Whether Acalabrutinib has been successfully included in medical insurance and what are the specific circumstances?
2026-02-01 22:25:32
Check Details
Pemigatinib is produced by Daxiong or Lucius
2026-02-01 22:25:32
Check Details
Is Erdafitinib/Bocco the latest new anti-tumor drug in China?
2026-02-01 22:25:32
Check Details
1
2
...
2251
2252
2253
2254
2255
2256
2257
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma